Kendle International Inc is a prominent global clinical research organization offering a comprehensive array of clinical development services to the biopharmaceutical sector. Founded in 1981, the company focuses on innovative solutions that shorten cycle times for its clients, thereby speeding up the introduction of life-improving products to the market for patients worldwide. As one of the largest providers of clinical development services globally, Kendle International Inc boasts experience in over 100 countries, delivers industry-leading patient access and retention capabilities, and brings extensive therapeutic expertise to address its clients' clinical development needs. The company's industries include Biotechnology and Health Care, and its headquarters is in the United States. At present, there is no publicly available information on the last investment or the last investment investors for Kendle International Inc.
There is no investment information
No recent news or press coverage available for Kendle International Inc.
We care about your data, and we'd love to use cookies make your experience better.
